↓ Skip to main content

Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study

Overview of attention for article published in BMC Ophthalmology, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study
Published in
BMC Ophthalmology, May 2014
DOI 10.1186/1471-2415-14-69
Pubmed ID
Authors

Dong Min Cha, Tae Wan Kim, Jang Won Heo, Se Joon Woo, Kyu Hyung Park, Hyeong Gon Yu, Hum Chung

Abstract

To compare the long-term efficacy of ranibizumab versus bevacizumab for myopic choroidal neovascularization (CNV).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Israel 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 21%
Other 5 15%
Researcher 3 9%
Student > Ph. D. Student 3 9%
Student > Doctoral Student 2 6%
Other 6 18%
Unknown 8 24%
Readers by discipline Count As %
Medicine and Dentistry 15 44%
Psychology 4 12%
Nursing and Health Professions 3 9%
Agricultural and Biological Sciences 2 6%
Business, Management and Accounting 1 3%
Other 1 3%
Unknown 8 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2015.
All research outputs
#18,372,841
of 22,756,196 outputs
Outputs from BMC Ophthalmology
#1,532
of 2,329 outputs
Outputs of similar age
#163,045
of 226,345 outputs
Outputs of similar age from BMC Ophthalmology
#17
of 38 outputs
Altmetric has tracked 22,756,196 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,329 research outputs from this source. They receive a mean Attention Score of 2.8. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,345 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.